Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, CAR-T cell therapy research, and Advanced Biosensing Techniques and Applications.
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Targeting a neoantigen derived from a common <i>TP53</i> mutation
Targeting public neoantigens for cancer immunotherapy
Bispecific antibodies targeting mutant<i>RAS</i>neoantigens
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes
Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses
TCR β chain–directed bispecific antibodies for the treatment of T cell cancers
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Author Correction: Targeting public neoantigens for cancer immunotherapy